Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis

Blood

Volumn 99, Issue 9, 2002, Pages 3419-3426

  Quo, Fei ^a   Nimmanapalli, Ramadevi ^a   Paranawithana, Shanthi ^a   Wittman, Sylvie ^a   Griffin, David ^a   Bali, Purva ^a   O'Bryan, Erica ^a   Fumero, Carlos ^a   Wang, Hong Gang ^a   Bhalla, Kapil ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; CASPASE 3; CASPASE 8; CYTOCHROME C; ENZYME ACTIVATOR; EPOTHILONE DERIVATIVE; INHIBITOR OF APOPTOSIS PROTEIN; IXABEPILONE; LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN CIAP1; SECOND MITOCHONDRIA DERIVED ACTIVATOR OF CASPASES; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0036565885     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3419     Document Type: Article

References (60)

1. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
2. Apoptosis signaling
3. The biochemistry of apoptosis
4. Death receptors: Signaling and modulation
5. An Apaf-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
6. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor receptor family
7. TRAIL a molecule with multiple receptors and control mechanisms
8. Safety and anti-tumor activity of recombinant soluble Apo2 ligand
9. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
10. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
11. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
12. Posttranslational n-myristoylation of Bid as a molecular switch for targeting mitochondria and apoptosis
13. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
14. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
15. Mitochondrial control of cell death
16. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
17. Molecular characterization of mitochondrial apoptosis-inducing factor
18. Endonuclease G is an apoptotic DNase when released from mitochondria
19. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
20. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade
21. Autoactivation of procaspase-9 by apaf-1 mediated oligomerization
22. An Apaf-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
23. IAP family proteins-suppressors of apoptosis
24. X-linked IAP is a direct inhibitor of cell-death proteases
25. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
26. Structural basis of caspase-7 inhibition by XIAP
27. Structural basis for the inhibition of caspase-3 by XIAP
28. Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain
29. XIAP regulates DNA damage-induced apoptosis downstream of caspase -9 cleavage
30. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells
31. Control of apoptosis and mitotic spindle checkpoint by survivin
32. BIRinging chromosomes through cell division - And survivin' the experience
33. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
34. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth
35. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
36. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
37. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain
38. Structural basis of IAP recognition by Smac/DIABLO
39. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
40. Structural and biochemical basis of apoptotic activation by Smac/DIABLO
41. BMS-247660: A novel epothilone analogue with a mode of action similar to paclitaxel but possessing superior antitumor efficacy
42. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome c and caspase-3 activity during Taxol-induced apoptosis
43. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
44. The role of Apaf-1, caspase -9 and bid proteins in etoposideor paclitaxel-induced mitochondrial events during apoptosis
45. L overexpression inhibits taxol-induced Yama protease activity and apoptosis
46. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
47. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
48. The caspase-8 inhibitor FLIP promotes activation of NFKB and Erk signaling pathways
49. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway
50. Antileukemic drugs increase death receptor 5 levels and enhance Apo2L-induced apoptosis of human acute leukemia cells
51. Pretreatment with paclitaxel enhances Apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels
52. Cotreatment with STI-571 enhances tumor necrosis factor α-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl positive human acute leukemia cells
53. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
54. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
55. Two CD95 (Apo-I/Fas) signaling pathways
56. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells
57. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human AML HL-60 cells
58. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
59. Phase I clinical and pharmacology study of the Epothilone B analog BMS-247550 given weekly in patients with advanced solid tumors
60. Mechanism of potentiation of epothilone-induced apoptosis of human ovarian cancer and leukemia cells by Apo-2/TRAIL and Smac peptide